Close Menu


Scientists from the University of California, San Francisco, and the Indiana University School of Medicine will receive 600 Illumina Omni BeadChips, and EA will process and analyze the data at no cost.

The partners will provide sequencing and analysis services to up to eight grant winners.

The genomics services firm hopes to eventually target clinicians.

After inking a similar deal with Dako earlier in the month, Quintiles announced this week that it would collaborate with pharmacogenetics firm London Genetics to provide personalized medicine services to drug developers. Financial terms of the deal were not disclosed.

The companies will provide biomarker and assay development services and consulting to biopharmas through a new alliance.

Dako and Quintiles have joined forces to develop companion diagnostics and drugs and to work with pharma to bring personalized medicine products to market.

As part of the new program, Illumina will provide the microarrays and reagents, and Expression Analysis will perform services and data analysis consultation relating to the genome-wide association studies, in both cases at no cost to the recipient.

Dako will develop cancer diagnostic tests, which Quintiles will perform as part of the clinical validation.

New Products: Oct 19, 2010


Genewiz's new Boston laboratory, Expression Analysis' single-lane sequencing services

The company expects to become the first commercial service provider for the real-time single-molecule sequencing technology in the US.


CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.